SHANGHAI - Zhejiang Jingxin Pharmaceutical Co. Ltd. has acquired a 51% stake in the US contract research organization (CRO) Pharmula Laboratories for $1.02m in cash, marking the first step by the
Fifteen Chinese formulation producers have recently acquired pharma quality certificates from 29 overseas countries including the U.S., Japan, and 27 European countries. The certified companies includ